2025-08-25 - Analysis Report
Okay, here's a report analyzing Colgate-Palmolive Co (CL) based on the data you provided.

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co. is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and pet nutrition products.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 14.10%
*   **VOO (S&P 500) Cumulative Return:** 38.83%
*   **Spread:** -24.73%
*   **Dispersion:** (Max: 7.9, Min: -89.0, Current: -85.0, Relative Dispersion: 4.1)

**Analysis:** CL has significantly underperformed the S&P 500 over the observed period. The relative dispersion of 4.1 suggests that the current underperformance is near the lowest end of its historical range compared to the S&P 500. This means, historically, CL has rarely underperformed VOO to this degree.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
|------------|--------|--------|--------|--------|--------|
| 2015-2017  | 13.0%  | 4.5%   | 13.0%  | 1.0    | 61.0   |
| 2016-2018  | -11.0% | 65.2%  | -11.0% | 1.0    | 48.1   |
| 2017-2019  | 7.0%   | 65.2%  | 7.0%   | 1.0    | 55.6   |
| 2018-2020  | 18.0%  | 65.2%  | 18.0%  | 1.0    | 69.1   |
| 2019-2021  | 30.0%  | 58.6%  | 29.0%  | 0.0    | 69.0   |
| 2020-2022  | 7.0%   | 69.0%  | 18.0%  | -0.0   | 63.7   |
| 2021-2023  | 6.0%   | 69.0%  | -4.0%  | -0.0   | 64.4   |
| 2022-2024  | 13.0%  | 69.0%  | -17.0% | -0.0   | 73.5   |
| 2023-2025  | 1.0%   | 70.6%  | -44.0% | 0.0    | 69.5   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Shows varied performance across different periods, with significant drops in recent years.
*   **MDD (Maximum Drawdown):** Indicates substantial risk, especially in more recent periods.
*   **Alpha:**  Alpha has become increasingly negative in recent periods, indicating underperformance relative to the market.
*   **Beta:** Beta is close to zero and in some years negative, indicating very low correlation with the market. This means Colgate-Palmolive's stock price does not move in tandem with the broader market. The company's performance is largely independent of overall market trends.
*   **Market Cap:** Consistent capitalization suggests a stable, large-cap company.

### 2. Recent Price Movement

*   **Current Price:** 85.94
*   **Last Market Data:** price: 85.94, previousClose: 86.28, change: -0.39
*   **5-Day Moving Average:** 85.68
*   **20-Day Moving Average:** 85.04
*   **60-Day Moving Average:** 88.30

**Analysis:** The stock price is currently trading slightly above both its 5-day and 20-day moving averages, but below its 60-day moving average. This suggests a possible short-term upward trend, but longer-term trend might still be down. The slight decrease from the previous close signals minor downward pressure.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3377 (Low Risk)
*   **RSI:** 63.75 (Approaching Overbought)
*   **PPO:** 0.40
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1209 shares - Safe (OverSold Boost) - MRI:0.32)
*   **20-Day Relative Dispersion Change:** 3.0 (+): Short-term increase
*   **Expected Return (%):** -837.9%

**Analysis:**

*   **MRI:** Indicates a low level of market risk, generally a positive sign.
*   **RSI:** RSI is approaching overbought territory (above 70), which could signal a potential pullback in the near term.
*   **PPO:** A positive PPO indicates that the short-term moving average is above the long-term moving average, suggesting an upward trend.
*   **Hybrid Signal:** Suggests a "Buy" signal based on oversold conditions and low market risk.
*   **20-Day Relative Dispersion Change:** Increasing relative dispersion indicates that the stock is outperforming its historical relationship with the S&P 500 in the short term.
*   **Expected Return (%):** The significantly negative expected return is a major cause for concern and warrants further investigation. It suggests that, based on the model, the stock is projected to significantly underperform the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **2025-08-24:** Major business developments, regulatory changes, or market events.
*   **2025-08-25:** Analysts discussing recent performance and outlook in the context of industry trends and global economic factors.
*   **2025-08-21:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-23:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news suggests the stock is experiencing volatility and is subject to both positive and negative pressures. It's important to investigate the specific details of these news items to understand the drivers behind these movements.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-08-01 | 0.92 | 5.11 B$  |
| 2025-04-25 | 0.85 | 4.91 B$  |
| 2024-10-25 | 0.9  | 5.03 B$  |
| 2024-07-26 | 0.89 | 5.06 B$  |
| 2025-08-01 | 0.89 | 5.06 B$  |

**Analysis:** Earnings per share (EPS) and revenue have been relatively stable over the recent quarters. While consistent, this stability may not be enough to excite investors seeking higher growth opportunities.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $5.11B  | 60.06%        |
| 2025-03-31 | $4.91B  | 60.82%        |
| 2024-12-31 | $4.95B  | 60.30%        |
| 2024-09-30 | $5.03B  | 61.08%        |
| 2024-06-30 | $5.06B  | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE        |
|------------|----------|------------|
| 2025-06-30 | $0.70B  | 105.84%    |
| 2025-03-31 | $0.36B  | 190.08%    |
| 2024-12-31 | $0.21B  | 348.58%    |
| 2024-09-30 | $0.43B  | 169.43%    |
| 2024-06-30 | $0.12B  | 594.31%    |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue is stable, and profit margins are consistently high, indicating strong pricing power and efficient cost management.
*   **Equity and ROE:** Equity has fluctuated, while ROE (Return on Equity) is exceptionally high. Very high ROE numbers like these often suggest either very efficient use of equity or that the equity base is very small, which can artificially inflate the ratio. You might want to investigate why the equity is so low.

### 7. Overall Summary

Based on the provided data, here's a summary of the analysis of Colgate-Palmolive (CL):

*   **Underperformance:** CL has significantly underperformed the S&P 500, with a large negative spread in cumulative returns.
*   **Low Market Correlation:** Beta is close to zero and in some years negative, indicating very low correlation with the market
*   **Stable Financials:** Revenue and profit margins are stable and high, indicating a mature, well-managed company. However, the equity is fluctuated and ROE is exceptionally high.
*   **Mixed Technical Signals:** The RSI is approaching overbought, while the MRI indicates low market risk.
*   **Negative Outlook:** The extremely negative expected return is a major red flag.
*   **Recent Volatility:** Recent news suggests that the stock is subject to various market forces.

**Conclusion:**

While Colgate-Palmolive exhibits stability in its financial performance, the underperformance relative to the S&P 500 and the extremely negative expected return are significant concerns. Investors should investigate the reasons behind the negative outlook and the low equity/high ROE before making any investment decisions. Monitor recent news and events that are influencing the stock's volatility.

**Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice. Always conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
